Compare FIVN & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIVN | PBH |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2014 | 2004 |
| Metric | FIVN | PBH |
|---|---|---|
| Price | $36.21 | $48.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 7 |
| Target Price | $36.70 | ★ $67.80 |
| AVG Volume (30 Days) | ★ 1.6M | 492.7K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 364.71 | N/A |
| EPS | 0.25 | ★ 0.61 |
| Revenue | ★ $1,149,088,000.00 | $975,777,000.00 |
| Revenue This Year | $10.31 | $17.03 |
| Revenue Next Year | $9.84 | $6.06 |
| P/E Ratio | $149.18 | ★ $79.69 |
| Revenue Growth | 10.28 | ★ 36.77 |
| 52 Week Low | $13.29 | $42.62 |
| 52 Week High | $40.00 | $71.07 |
| Indicator | FIVN | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 53.95 | 54.09 |
| Support Level | $31.33 | $47.61 |
| Resistance Level | $37.34 | $50.00 |
| Average True Range (ATR) | 2.16 | 1.41 |
| MACD | 0.18 | 0.05 |
| Stochastic Oscillator | 66.20 | 59.02 |
Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Intelligent CX platform combines core telephony functionality, omnichannel engagement, and modules into a cloud-based contact-center-as-a-service platform. Five9's modules include digital self-service, agent assist technology, workflow automation, and optimization solutions, as well as artificial intelligence-driven automation solutions that optimize customer service efficiency and manage interaction quality and agent performance.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.